An FDA-Approved Tenofovir Alafenamide-Based Antiretroviral Therapy Reduces Biological Age in Healthy Adults: First Human Proof-of-Concept for Retrotransposon-Targeted Gerotherapeutics
FDA批准的基于替诺福韦艾拉酚胺的抗逆转录病毒疗法可降低健康成年人的生物年龄:首个针对逆转录转座子的抗衰老疗法的人体概念验证
期刊:
影响因子:
doi:10.64898/2026.03.23.26349105
Anderson, Peter L; Pang, Alina Ps; Coyle, Ryan P; Schlachetzki, Johannes; Molina, Anthony J A; Bushman, Lane; Aguado, Julio; Hill, Blake; Liu, Albert Y; Brooks, Kristina M; Erlandson, Kristine M; Corley, Michael J